BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26168268)

  • 1. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
    Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
    J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.
    Ranieri A; Kemp E; Burgoyne JR; Avkiran M
    J Mol Cell Cardiol; 2018 Feb; 115():20-31. PubMed ID: 29294329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit.
    Ahn JH; McAvoy T; Rakhilin SV; Nishi A; Greengard P; Nairn AC
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2979-84. PubMed ID: 17301223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
    Biswas D; Cary W; Nolta JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth.
    Haesen D; Abbasi Asbagh L; Derua R; Hubert A; Schrauwen S; Hoorne Y; Amant F; Waelkens E; Sablina A; Janssens V
    Cancer Res; 2016 Oct; 76(19):5719-5731. PubMed ID: 27485451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta.
    Louis JV; Martens E; Borghgraef P; Lambrecht C; Sents W; Longin S; Zwaenepoel K; Pijnenborg R; Landrieu I; Lippens G; Ledermann B; Götz J; Van Leuven F; Goris J; Janssens V
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6957-62. PubMed ID: 21482799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction.
    Lenaerts L; Reynhout S; Verbinnen I; Laumonnier F; Toutain A; Bonnet-Brilhault F; Hoorne Y; Joss S; Chassevent AK; Smith-Hicks C; Loeys B; Joset P; Steindl K; Rauch A; Mehta SG; Chung WK; Devriendt K; Holder SE; Jewett T; Baldwin LM; Wilson WG; Towner S; Srivastava S; Johnson HF; Daumer-Haas C; Baethmann M; Ruiz A; Gabau E; Jain V; Varghese V; Al-Beshri A; Fulton S; Wechsberg O; Orenstein N; Prescott K; Childs AM; Faivre L; Moutton S; Sullivan JA; Shashi V; Koudijs SM; Heijligers M; Kivuva E; McTague A; Male A; van Ierland Y; Plecko B; Maystadt I; Hamid R; Hannig VL; Houge G; Janssens V
    Genet Med; 2021 Feb; 23(2):352-362. PubMed ID: 33106617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B'δ holoenzyme.
    Jong CJ; Merrill RA; Wilkerson EM; Herring LE; Graves LM; Strack S
    J Biol Chem; 2020 Apr; 295(17):5654-5668. PubMed ID: 32156701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domains necessary for Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12 a novel regulatory subunit of PP2A?
    Zhu D; Tate RI; Ruediger R; Meigs TE; Denker BM
    Mol Pharmacol; 2007 May; 71(5):1268-76. PubMed ID: 17303700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B56δ subunit of protein phosphatase 2A decreases phosphorylation of endothelial nitric oxide synthase at serine 116: Mechanism underlying aphidicolin-stimulated NO production.
    Park JH; Cho DH; Lee JY; Lee HJ; Ha Y; Ahn JH; Jo I
    Nitric Oxide; 2015 Nov; 50():46-51. PubMed ID: 26255574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations.
    Wu CG; Balakrishnan VK; Merrill RA; Parihar PS; Konovolov K; Chen YC; Xu Z; Wei H; Sundaresan R; Cui Q; Wadzinski BE; Swingle MR; Musiyenko A; Chung WK; Honkanen RE; Suzuki A; Huang X; Strack S; Xing Y
    Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2310727120. PubMed ID: 38150499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum-based modeling implies that bidentate Arg
    Salter EA; Wierzbicki A; Honkanen RE; Swingle MR
    Front Cell Dev Biol; 2023; 11():1141804. PubMed ID: 37377738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo.
    Lambrecht C; Libbrecht L; Sagaert X; Pauwels P; Hoorne Y; Crowther J; Louis JV; Sents W; Sablina A; Janssens V
    Oncogene; 2018 Jan; 37(4):544-552. PubMed ID: 28967903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPP2R1A neurodevelopmental disorder is associated with congenital heart defects.
    Baker EK; Solivio B; Pode-Shakked B; Cross LA; Sullivan B; Raas-Rothschild A; Chorin O; Barel O; Bar-Yosef O; Husami A; Hopkin RJ; Prada CE; Stottmann RW; Weaver KN
    Am J Med Genet A; 2022 Nov; 188(11):3262-3277. PubMed ID: 36209351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity.
    Low IC; Loh T; Huang Y; Virshup DM; Pervaiz S
    Blood; 2014 Oct; 124(14):2223-34. PubMed ID: 25082878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.
    Sandal P; Jong CJ; Merrill RA; Song J; Strack S
    J Cell Sci; 2021 Jul; 134(13):. PubMed ID: 34228795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein Phosphorylation.
    Yu UY; Yoo BC; Ahn JH
    Korean J Physiol Pharmacol; 2014 Apr; 18(2):155-61. PubMed ID: 24757378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics of a novel rare
    Verbinnen I; Procknow SS; Lenaerts L; Reynhout S; Mehregan A; Ulens C; Janssens V; King KA
    Front Cell Dev Biol; 2022; 10():1059938. PubMed ID: 36531959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.